JOSE GAMEZ: Open Payments
NPI 1134210271 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75,935 in 146 payments from 16 companies in 2025. Trend: 2023 $162,794 · 2024 $117,252 · 2025 $75,935
Speaker / faculty: $51,336Consulting: $14,538Travel & lodging: $5,206Food & beverage: $4,855
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 27 | $23,109 |
| Neurocrine BioSciences, Inc. | 29 | $22,981 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $13,924 |
| Otsuka America Pharmaceutical, Inc. | 11 | $7,687 |
| ABBVIE INC. | 9 | $5,649 |
| Teva Pharmaceuticals USA, Inc. | 14 | $735 |
| E.R. Squibb & Sons, L.L.C. | 5 | $594 |
| Alkermes, Inc. | 12 | $510 |
| Eisai Inc. | 1 | $125 |
| Bausch Health US, LLC | 5 | $116 |
Products named: NUPLAZID, INGREZZA, CAPLYTA, REXULTI, VRAYLAR, AUSTEDO XR, COBENFY, LYBALVI.
Industry payments across FL — which companies pay providers there.
